0 XP   0   0   0

Microbix Biosystems Inc.
Buy, Hold or Sell?

I guess you are interested in Microbix Biosystems Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Microbix

Let's start. I'm going to help you getting a better view of Microbix Biosystems Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Microbix Biosystems Inc. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Microbix Biosystems Inc. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Microbix Biosystems Inc.. The closing price on 2022-09-30 was $0.373 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Microbix Biosystems Inc. Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Microbix Biosystems Inc..

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Microbix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • A Net Profit Margin of 12.7% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 12.7%. The company is making a huge profit. +2
  • The TTM is 14.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.7%TTM14.9%-2.2%
TTM14.9%YOY-33.4%+48.4%
TTM14.9%5Y-21.0%+36.0%
5Y-21.0%10Y-11.3%-9.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.7%-256.4%+269.1%
TTM14.9%-281.5%+296.4%
YOY-33.4%-344.8%+311.4%
5Y-21.0%-492.0%+471.0%
10Y-11.3%-561.7%+550.4%
1.1.2. Return on Assets

Shows how efficient Microbix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • 1.9% Return on Assets means that Microbix generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Microbix Biosystems Inc.:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM2.4%-0.5%
TTM2.4%YOY-5.2%+7.6%
TTM2.4%5Y-3.2%+5.7%
5Y-3.2%10Y-1.5%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%-9.9%+11.8%
TTM2.4%-8.7%+11.1%
YOY-5.2%-9.3%+4.1%
5Y-3.2%-11.6%+8.4%
10Y-1.5%-12.3%+10.8%
1.1.3. Return on Equity

Shows how efficient Microbix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • 2.6% Return on Equity means Microbix generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Microbix Biosystems Inc.:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM3.5%-0.9%
TTM3.5%YOY-13.6%+17.1%
TTM3.5%5Y-7.0%+10.5%
5Y-7.0%10Y-3.1%-3.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-12.0%+14.6%
TTM3.5%-10.9%+14.4%
YOY-13.6%-10.7%-2.9%
5Y-7.0%-13.8%+6.8%
10Y-3.1%-14.7%+11.6%

1.2. Operating Efficiency of Microbix Biosystems Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Microbix is operating .

  • Measures how much profit Microbix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • An Operating Margin of 16.1% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 16.1%. The company is operating efficient. +1
  • The TTM is 21.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ16.1%TTM21.6%-5.5%
TTM21.6%YOY16.7%+4.9%
TTM21.6%5Y8.5%+13.2%
5Y8.5%10Y4.2%+4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.1%-232.1%+248.2%
TTM21.6%-266.2%+287.8%
YOY16.7%-311.8%+328.5%
5Y8.5%-472.5%+481.0%
10Y4.2%-560.3%+564.5%
1.2.2. Operating Ratio

Measures how efficient Microbix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.29 means that the operating costs are $1.29 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 1.287. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.176. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.176+0.110
TTM1.176YOY1.300-0.124
TTM1.1765Y1.422-0.245
5Y1.42210Y1.006+0.416
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2873.270-1.983
TTM1.1763.490-2.314
YOY1.3003.442-2.142
5Y1.4225.620-4.198
10Y1.0066.585-5.579

1.3. Liquidity of Microbix Biosystems Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Microbix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.84 means the company has $7.84 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 7.842. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.800. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.842TTM5.800+2.042
TTM5.800YOY2.274+3.526
TTM5.8005Y2.476+3.324
5Y2.47610Y1.311+1.165
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8425.117+2.725
TTM5.8005.755+0.045
YOY2.2745.878-3.604
5Y2.4766.514-4.038
10Y1.3116.212-4.901
1.3.2. Quick Ratio

Measures if Microbix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • A Quick Ratio of 0.84 means the company can pay off $0.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.841. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.071. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.841TTM1.071-0.230
TTM1.071YOY0.585+0.486
TTM1.0715Y0.535+0.536
5Y0.53510Y0.285+0.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8413.813-2.972
TTM1.0714.348-3.277
YOY0.5854.712-4.127
5Y0.5354.779-4.244
10Y0.2854.467-4.182

1.4. Solvency of Microbix Biosystems Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Microbix assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.26 means that Microbix assets are financed with 25.7% credit (debt) and the remaining percentage (100% - 25.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.257. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.257TTM0.295-0.038
TTM0.295YOY0.510-0.215
TTM0.2955Y0.418-0.123
5Y0.41810Y0.455-0.037
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2570.274-0.017
TTM0.2950.274+0.021
YOY0.5100.304+0.206
5Y0.4180.366+0.052
10Y0.4550.400+0.055
1.4.2. Debt to Equity Ratio

Measures if Microbix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 34.6% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.346. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.422. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.346TTM0.422-0.077
TTM0.422YOY1.100-0.678
TTM0.4225Y0.765-0.342
5Y0.76510Y0.935-0.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3460.311+0.035
TTM0.4220.315+0.107
YOY1.1000.321+0.779
5Y0.7650.398+0.367
10Y0.9350.454+0.481

2. Market Valuation of Microbix Biosystems Inc.

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Microbix.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 16.84 means the investor is paying $16.84 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 16.398. Neutral. Compare to industry.
  • The MRQ is 16.838. Neutral. Compare to industry.
  • The TTM is 17.661. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD16.398MRQ16.838-0.440
MRQ16.838TTM17.661-0.824
TTM17.661YOY-9.410+27.071
TTM17.6615Y-32.693+50.355
5Y-32.69310Y-1.574-31.119
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.398-2.215+18.613
MRQ16.838-2.524+19.362
TTM17.661-4.050+21.711
YOY-9.410-5.007-4.403
5Y-32.693-3.850-28.843
10Y-1.574-3.475+1.901
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Microbix.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is -0.088. Very Bad. -2
  • The TTM is -0.106. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.088TTM-0.106+0.018
TTM-0.106YOY-0.110+0.004
TTM-0.1065Y0.489-0.595
5Y0.48910Y0.078+0.411
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0880.005-0.093
TTM-0.1060.022-0.128
YOY-0.1100.043-0.153
5Y0.4890.024+0.465
10Y0.0780.020+0.058

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Microbix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.12 means the investor is paying $2.12 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 2.069. Good. +1
  • The MRQ is 2.125. Good. +1
  • The TTM is 3.039. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.069MRQ2.125-0.055
MRQ2.125TTM3.039-0.915
TTM3.039YOY4.271-1.231
TTM3.0395Y1.723+1.317
5Y1.72310Y0.861+0.861
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.0691.932+0.137
MRQ2.1252.138-0.013
TTM3.0392.946+0.093
YOY4.2713.587+0.684
5Y1.7232.909-1.186
10Y0.8612.520-1.659

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Microbix Biosystems Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.1800.167+8%0.084+114%0.066+173%0.033+445%
Book Value Per Share Growth--0.0060.011-41%0.008-19%0.016-61%0.016-61%
Current Ratio--7.8425.800+35%2.274+245%2.476+217%1.311+498%
Debt To Asset Ratio--0.2570.295-13%0.510-50%0.418-39%0.455-44%
Debt To Equity Ratio--0.3460.422-18%1.100-69%0.765-55%0.935-63%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0050.006-18%-0.006+234%-0.004+183%-0.003+155%
Eps Growth---191.585-169.130-12%462.450-141%331.834-158%70.581-371%
Gains Per Share--0.0060.011-41%0.008-19%0.016-61%0.016-61%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Net Profit Margin--0.1270.149-15%-0.334+362%-0.210+265%-0.113+189%
Operating Margin--0.1610.216-25%0.167-3%0.085+91%0.042+284%
Operating Ratio--1.2871.176+9%1.300-1%1.422-9%1.006+28%
Pb Ratio2.069-3%2.1253.039-30%4.271-50%1.723+23%0.861+147%
Pe Ratio16.398-3%16.83817.661-5%-9.410+156%-32.693+294%-1.574+109%
Peg Ratio---0.088-0.106+20%-0.110+25%0.489-118%0.078-213%
Price Per Share0.373-3%0.3830.501-24%0.345+11%0.273+40%0.246+56%
Quick Ratio--0.8411.071-21%0.585+44%0.535+57%0.285+195%
Return On Assets--0.0190.024-21%-0.052+371%-0.032+269%-0.015+179%
Return On Equity--0.0260.035-25%-0.136+628%-0.070+371%-0.031+222%
 EOD+3 -0MRQTTM+7 -11YOY+11 -75Y+12 -610Y+12 -7

3.2. Fundamental Score

Let's check the fundamental score of Microbix Biosystems Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.398
Price to Book Ratio (EOD)Between0-12.069
Net Profit Margin (MRQ)Greater than00.127
Operating Margin (MRQ)Greater than00.161
Quick Ratio (MRQ)Greater than10.841
Current Ratio (MRQ)Greater than17.842
Debt to Asset Ratio (MRQ)Less than10.257
Debt to Equity Ratio (MRQ)Less than10.346
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.019
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Microbix Biosystems Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.124
Ma 20Greater thanMa 500.391
Ma 50Greater thanMa 1000.397
Ma 100Greater thanMa 2000.394
OpenGreater thanClose0.373
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets33,296
Total Liabilities8,551
Total Stockholder Equity24,745
 As reported
Total Liabilities 8,551
Total Stockholder Equity+ 24,745
Total Assets = 33,296

Assets

Total Assets33,296
Total Current Assets23,476
Long-term Assets23,476
Total Current Assets
Cash And Cash Equivalents 14,163
Net Receivables 2,518
Other Current Assets 6,825
Total Current Assets  (as reported)23,476
Total Current Assets  (calculated)23,507
+/- 31
Long-term Assets
Property Plant Equipment 8,284
Long-term Assets  (as reported)9,821
Long-term Assets  (calculated)8,284
+/- 1,537

Liabilities & Shareholders' Equity

Total Current Liabilities2,993
Long-term Liabilities5,558
Total Stockholder Equity24,745
Total Current Liabilities
Short Long Term Debt 111
Accounts payable 1,520
Other Current Liabilities 1,192
Total Current Liabilities  (as reported)2,993
Total Current Liabilities  (calculated)2,823
+/- 170
Long-term Liabilities
Other Liabilities 5,558
Long-term Liabilities  (as reported)5,558
Long-term Liabilities  (calculated)5,558
+/-0
Total Stockholder Equity
Common Stock49,127
Retained Earnings -36,408
Other Stockholders Equity 2,273
Total Stockholder Equity (as reported)24,745
Total Stockholder Equity (calculated)14,991
+/- 9,754
Other
Capital Stock49,127
Common Stock Shares Outstanding 137,291
Net Invested Capital 29,530
Net Tangible Assets 23,208
Net Working Capital 20,482



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-09-302000-06-302000-03-31
> Total Assets 
1,851
1,935
1,925
1,971
2,067
1,881
1,725
1,673
1,781
1,715
1,954
1,958
2,180
2,201
2,096
2,304
2,306
2,674
2,914
3,062
3,396
3,549
4,254
4,409
3,547
3,267
3,482
5,765
5,852
11,965
11,251
11,208
13,719
11,590
11,554
11,987
13,177
12,788
14,094
12,696
13,907
13,426
17,520
17,608
13,152
13,258
14,001
13,180
13,752
12,832
12,798
12,166
12,334
11,712
13,570
15,011
16,072
16,214
17,346
17,801
17,685
17,002
18,569
19,424
19,230
18,518
19,413
20,211
21,135
21,868
26,866
28,180
19,310
19,928
20,304
20,322
19,630
19,756
20,692
20,485
15,598
16,287
17,956
25,864
28,829
31,226
32,947
33,296
33,29632,94731,22628,82925,86417,95616,28715,59820,48520,69219,75619,63020,32220,30419,92819,31028,18026,86621,86821,13520,21119,41318,51819,23019,42418,56917,00217,68517,80117,34616,21416,07215,01113,57011,71212,33412,16612,79812,83213,75213,18014,00113,25813,15217,60817,52013,42613,90712,69614,09412,78813,17711,98711,55411,59013,71911,20811,25111,9655,8525,7653,4823,2673,5474,4094,2543,5493,3963,0622,9142,6742,3062,3042,0962,2012,1801,9581,9541,7151,7811,6731,7251,8812,0671,9711,9251,9351,851
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,752
4,236
4,403
4,926
5,191
5,843
6,959
6,067
6,793
7,330
7,387
6,452
6,161
7,094
6,700
6,493
7,136
8,840
16,805
19,094
21,548
23,127
23,476
23,47623,12721,54819,09416,8058,8407,1366,4936,7007,0946,1616,4527,3877,3306,7936,0676,9595,8435,1914,9264,4034,2363,75200000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
93
519
643
6,262
4,355
3,320
3,201
859
437
666
550
115
763
93
16
194
153
202
119
184
499
554
232
176
123
50
252
196
1,041
424
488
681
880
0
78
48
5
4
4
1
25
126
43
41
92
56
44
276
25
14
96
70
168
402
93
417
1,545
7,507
9,986
10,495
12,201
14,163
14,16312,20110,4959,9867,5071,54541793402168709614252764456924143126251445487808806814884241,0411962525012317623255449918411920215319416937631155506664378593,2013,3204,3556,26264351993850000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000001980000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
970
1,162
783
1,189
1,376
1,038
2,028
1,406
1,078
1,854
1,849
1,777
1,257
2,008
1,304
1,887
1,896
2,124
4,180
4,206
5,591
4,578
2,518
2,5184,5785,5914,2064,1802,1241,8961,8871,3042,0081,2571,7771,8491,8541,0781,4062,0281,0381,3761,1897831,16297000000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
28
27
30
61
73
58
54
62
55
21
34
80
68
34
29
37
38
36
43
67
66
45
62
104
64
54
96
93
78
64
859
134
124
100
99
71
106
59
123
86
97
88
121
108
169
52
95
101
151
102
99
68
74
83
275
345
246
241
145
333
163
91
71
53
43
46
67
86
122
75
93
172
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,825
6,825000000000000001701729375122866746435371911633331452412463452758374689910215110195521691081218897861235910671991001241348596478939654641046245666743363837293468803421556254587361302728
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,975
12,935
13,177
13,595
13,598
13,785
9,105
9,151
9,116
9,059
9,735
9,678
9,820
9,821
9,8219,8209,6789,7359,0599,1169,1519,10513,78513,59813,59513,17712,93512,97500000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
994
947
906
830
863
819
789
770
796
745
751
796
846
849
864
857
831
872
900
951
1,100
1,273
1,429
1,448
1,571
1,526
1,526
1,734
1,841
1,777
1,929
3,970
4,353
4,965
5,321
5,971
6,359
6,473
6,676
6,306
6,498
6,625
6,710
6,657
6,079
6,188
6,290
6,073
6,238
6,112
5,928
5,669
5,750
5,594
5,750
7,086
7,815
8,430
9,249
10,175
8,913
8,688
9,360
9,446
9,332
9,090
9,141
9,494
9,763
10,180
12,861
13,090
6,647
6,573
6,539
6,534
6,650
7,103
7,139
7,361
7,363
7,443
7,388
7,368
8,083
8,064
8,245
8,284
8,2848,2458,0648,0837,3687,3887,4437,3637,3617,1397,1036,6506,5346,5396,5736,64713,09012,86110,1809,7639,4949,1419,0909,3329,4469,3608,6888,91310,1759,2498,4307,8157,0865,7505,5945,7505,6695,9286,1126,2386,0736,2906,1886,0796,6576,7106,6256,4986,3066,6766,4736,3595,9715,3214,9654,3533,9701,9291,7771,8411,7341,5261,5261,5711,4481,4291,2731,100951900872831857864849846796751745796770789819863830906947994
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
240
234
229
235
230
217
214
228
1,697
1,662
1,591
1,577
4,092
3,561
3,417
3,685
4,004
4,047
4,169
3,954
4,067
4,156
4,248
4,252
3,895
3,971
4,063
3,935
4,050
4,002
3,866
3,721
3,767
3,635
3,783
4,041
3,619
3,501
3,190
3,347
4,026
4,175
4,530
4,655
4,725
4,723
4,962
5,095
5,183
5,238
6,582
6,551
5,016
4,982
4,947
4,912
4,959
4,924
4,890
4,855
1,742
1,707
0
0
1,652
0
0
0
0001,652001,7071,7424,8554,8904,9244,9594,9124,9474,9825,0166,5516,5825,2385,1835,0954,9624,7234,7254,6554,5304,1754,0263,3473,1903,5013,6194,0413,7833,6353,7673,7213,8664,0024,0503,9354,0633,9713,8954,2524,2484,1564,0673,9544,1694,0474,0043,6853,4173,5614,0921,5771,5911,6621,69722821421723023522923424000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
784
661
757
671
662
578
557
489
483
380
709
676
843
732
679
751
986
864
847
882
1,016
1,195
1,608
1,796
2,222
2,181
2,539
2,848
3,549
3,665
3,793
5,145
6,560
5,798
6,185
6,741
7,180
7,378
7,556
7,500
8,420
7,828
8,936
9,061
8,250
8,484
8,572
8,227
9,554
8,990
8,865
8,454
6,785
6,217
7,156
7,682
7,284
7,080
7,188
7,298
7,413
6,920
7,640
8,325
7,582
7,147
7,704
7,978
9,004
7,172
8,556
9,699
8,957
9,660
9,612
9,781
9,092
9,776
8,744
8,931
8,979
9,243
9,741
9,150
10,273
9,028
9,133
8,551
8,5519,1339,02810,2739,1509,7419,2438,9798,9318,7449,7769,0929,7819,6129,6608,9579,6998,5567,1729,0047,9787,7047,1477,5828,3257,6406,9207,4137,2987,1887,0807,2847,6827,1566,2176,7858,4548,8658,9909,5548,2278,5728,4848,2509,0618,9367,8288,4207,5007,5567,3787,1806,7416,1855,7986,5605,1453,7933,6653,5492,8482,5392,1812,2221,7961,6081,1951,016882847864986751679732843676709380483489557578662671757661784
   > Total Current Liabilities 
318
230
558
529
400
483
471
410
425
348
359
335
471
519
453
334
572
422
376
407
456
539
626
766
922
660
745
874
950
1,057
1,232
1,060
2,129
1,870
1,648
1,547
1,554
1,565
1,499
1,704
2,466
1,586
2,487
2,603
2,288
2,294
2,141
1,887
2,720
2,164
2,148
1,890
1,429
1,038
1,282
1,567
2,357
1,826
2,428
2,358
3,106
2,979
3,876
4,613
3,998
3,748
4,346
4,669
5,209
3,263
3,797
5,001
4,161
4,989
5,062
5,353
4,766
4,868
3,822
4,096
4,090
4,396
4,740
4,180
5,194
4,146
3,566
2,993
2,9933,5664,1465,1944,1804,7404,3964,0904,0963,8224,8684,7665,3535,0624,9894,1615,0013,7973,2635,2094,6694,3463,7483,9984,6133,8762,9793,1062,3582,4281,8262,3571,5671,2821,0381,4291,8902,1482,1642,7201,8872,1412,2942,2882,6032,4871,5862,4661,7041,4991,5651,5541,5471,6481,8702,1291,0601,2321,057950874745660922766626539456407376422572334453519471335359348425410471483400529558230318
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,008
5,246
5,314
2,003
1,057
1,352
1,660
1,383
1,793
2,145
2,618
2,582
2,256
0
0
0
0
0
0
0
0
0
0
00000000002,2562,5822,6182,1451,7931,3831,6601,3521,0572,0035,3145,2465,00800000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,008
5,246
5,314
2,003
1,057
1,352
1,660
1,383
1,793
2,145
2,618
2,582
2,256
1,150
1,138
1,127
1,140
1,177
1,217
2,447
1,071
602
111
1116021,0712,4471,2171,1771,1401,1271,1381,1502,2562,5822,6182,1451,7931,3831,6601,3521,0572,0035,3145,2465,00800000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
215
128
260
254
262
225
226
176
188
163
287
233
369
417
376
267
353
372
289
299
438
481
566
703
852
576
658
782
857
973
1,158
997
2,097
1,843
1,627
1,531
1,476
1,487
1,419
1,631
1,868
1,353
1,786
1,889
1,976
1,979
1,849
1,761
1,950
1,643
1,539
1,392
1,312
778
1,174
1,448
1,631
1,120
1,716
1,673
1,869
1,476
1,598
1,666
1,446
1,462
1,614
1,811
2,272
1,443
1,456
1,913
1,767
1,610
1,594
1,580
1,463
1,581
1,355
1,378
1,488
1,599
2,212
1,736
1,795
1,812
1,495
1,520
1,5201,4951,8121,7951,7362,2121,5991,4881,3781,3551,5811,4631,5801,5941,6101,7671,9131,4561,4432,2721,8111,6141,4621,4461,6661,5981,4761,8691,6731,7161,1201,6311,4481,1747781,3121,3921,5391,6431,9501,7611,8491,9791,9761,8891,7861,3531,8681,6311,4191,4871,4761,5311,6271,8432,0979971,158973857782658576852703566481438299289372353267376417369233287163188176226225262254260128215
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153
0
66
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205
159
111
57
50
0
0
0
143
145
0
0
0
0
0
0
0
0
0
0
143
143
326
904
520
676
844
853
915
699
902
1,346
931
1,507
1,244
1,075
640
856
1,156
1,418
1,316
1,501
1,197
1,078
743
1,064
1,285
1,192
1,1921,2851,0647431,0781,1971,5011,3161,4181,1568566401,0751,2441,5079311,34690269991585384467652090432614314300000000001451430005057111159205000000000000000000001086601530000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,550
4,428
4,326
4,909
4,921
4,835
4,888
4,847
5,001
4,969
5,079
4,882
5,567
5,558
5,5585,5674,8825,0794,9695,0014,8474,8884,8354,9214,9094,3264,4284,55000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
27
28
30
215
220
237
278
730
752
758
793
795
726
463
493
488
498
518
497
516
536
553
559
516
534
553
542
419
416
406
392
401
389
374
387
369
355
326
331
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,558
5,5580000000000000000000000000003313263553693873743894013924064164195425535345165595535365164975184984884934637267957937587527302782372202153028272800000000000000000000
> Total Stockholder Equity
1,068
1,275
1,168
1,300
1,404
1,303
1,168
1,185
1,299
1,335
1,245
1,282
1,337
1,470
1,417
1,553
1,320
1,810
2,067
2,180
2,379
2,354
2,646
2,614
1,325
1,086
943
2,917
2,303
8,300
7,458
6,062
7,159
5,792
5,370
5,245
5,997
5,410
6,538
5,195
5,487
5,598
5,286
5,226
4,902
4,774
5,429
4,953
4,198
3,842
3,933
3,712
5,549
5,496
6,414
7,329
8,788
9,133
10,158
10,503
10,272
10,082
10,929
11,099
11,647
11,371
11,710
12,233
12,131
14,697
18,310
18,481
10,354
10,268
10,692
10,540
10,537
9,980
11,948
11,554
6,619
7,044
8,215
16,714
18,556
22,198
23,814
24,745
24,74523,81422,19818,55616,7148,2157,0446,61911,55411,9489,98010,53710,54010,69210,26810,35418,48118,31014,69712,13112,23311,71011,37111,64711,09910,92910,08210,27210,50310,1589,1338,7887,3296,4145,4965,5493,7123,9333,8424,1984,9535,4294,7744,9025,2265,2865,5985,4875,1956,5385,4105,9975,2455,3705,7927,1596,0627,4588,3002,3032,9179431,0861,3252,6142,6462,3542,3792,1802,0671,8101,3201,5531,4171,4701,3371,2821,2451,3351,2991,1851,1681,3031,4041,3001,1681,2751,068
   Retained Earnings -36,408-37,046-37,780-38,661-39,440-40,956-41,763-41,894-36,911-36,471-36,252-35,666-35,618-35,426-35,818-35,698-27,513-27,513-21,659-21,646-20,106-19,722-19,73000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.